Biaryl Ether Retrohydroxamates as Potent, Long-lived, Orally Bioavailable MMP Inhibitors
作者:Michael R. Michaelides、Joseph F. Dellaria、Jane Gong、James H. Holms、Jennifer J. Bouska、Jamie Stacey、Carol K. Wada、H.Robin Heyman、Michael L. Curtin、Yan Guo、Carole L. Goodfellow、Ildiko B. Elmore、Daniel H. Albert、Terrance J. Magoc、Patrick A. Marcotte、Douglas W. Morgan、Steven K. Davidsen
DOI:10.1016/s0960-894x(01)00031-2
日期:2001.6
A novel series of biaryl ether reverse hydroxamate MMP inhibitors has been developed. These compounds are potent MMP-2 inhibitors with limited activity against MMP-1. Select members of this series exhibit excellent pharmacokinetic properties with long elimination half-lives (7 h) and high oral bioavailability (100%). (C) 2001 Elsevier Science Ltd. All rights reserved.